Response by Wang to “Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts”

Peng-Hui Wang

Open source

DOI: 10.3802/jgo.2026.37.e154
Published: 2026
Container: Journal of Gynecologic Oncology
Publisher: XMLink
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3802/jgo.2026.37.e154,
  title = {Response by Wang to “Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts”},
  author = {Peng-Hui Wang},
  year = {2026},
  journal = {Journal of Gynecologic Oncology},
  doi = {10.3802/jgo.2026.37.e154},
  url = {https://doi.org/10.3802/jgo.2026.37.e154}
}

RIS

TY  - JOUR
TI  - Response by Wang to “Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts”
AU  - Peng-Hui Wang
PY  - 2026
JO  - Journal of Gynecologic Oncology
DO  - 10.3802/jgo.2026.37.e154
UR  - https://doi.org/10.3802/jgo.2026.37.e154
ER  -

APA

Wang, P. (2026). Response by Wang to “Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts”. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e154

Source records

crossref · retrieved 2026-11-08T06:09:47.259Z